Psychiatry and Psychology [F] » Mental Disorders [F03] » Neurodevelopmental Disorders » Attention Deficit and Disruptive Behavior Disorders » Attention Deficit Disorder with Hyperactivity
Description
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) MeSH
Hierarchy View
Approved Indicated Drugs (18)
Phase 4 Indicated Drugs (18)
Phase 2 Indicated Drugs (32)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (11)
Organization Involved with Phase 4 Indications (113)
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
Centre de Salut Mental Infanto-Juvenil, Lleida
Child and adolescent Psychiatric department, South Jutland
Children's National Medical Center
Children's Specialized Hospital
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Federal University of Rio Grande do Sul
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
JPM van Stralen Medicine Professional
Korea Health Industry Development Institute
Massachusetts Institute of Technology
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Rochester Center for Behavioral Medicine
Skyland Behavioral Health Associates
State University of New York, Buffalo
Organization Involved with Phase 3 Indications (56)
Albert Einstein Israelite Hospital
Assistance Publique - Hôpitaux de Paris
Engelhard Arzneimittel GmbH & Co.KG
Ironshore Pharmaceuticals and Development, Inc
Medice Arzneimittel Pütter GmbH & Co KG
National Institute of Neurological Disorders and Stroke (NINDS)
Organization Involved with Phase 2 Indications (45)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (31)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
